820 related articles for article (PubMed ID: 24334129)
21. Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome.
Yoshida H; Horie M; Otani H; Takano M; Tsuji K; Kubota T; Fukunami M; Sasayama S
J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1262-70. PubMed ID: 10517660
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.
Hayashi K; Shimizu M; Ino H; Yamaguchi M; Mabuchi H; Hoshi N; Higashida H
Cardiovasc Res; 2002 Apr; 54(1):67-76. PubMed ID: 12062363
[TBL] [Abstract][Full Text] [Related]
23. Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death.
Clancy CE; Rudy Y
Cardiovasc Res; 2001 May; 50(2):301-13. PubMed ID: 11334834
[TBL] [Abstract][Full Text] [Related]
24. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel.
El Harchi A; Melgari D; Zhang YH; Zhang H; Hancox JC
PLoS One; 2012; 7(12):e52451. PubMed ID: 23300672
[TBL] [Abstract][Full Text] [Related]
25. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
26. Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Liu QN; Trudeau MC
PLoS One; 2015; 10(4):e0123951. PubMed ID: 25923442
[TBL] [Abstract][Full Text] [Related]
27. Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2.
Aidery P; Kisselbach J; Gaspar H; Baldea I; Schweizer PA; Becker R; Katus HA; Thomas D
Biochem Biophys Res Commun; 2012 Feb; 418(4):830-5. PubMed ID: 22314138
[TBL] [Abstract][Full Text] [Related]
28. The inherited long QT syndrome: from ion channel to bedside.
Vincent GM; Timothy K; Fox J; Zhang L
Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the HERG K+-ion channel: a novel link between long QT syndrome and sudden infant death syndrome.
Christiansen M; Tønder N; Larsen LA; Andersen PS; Simonsen H; Oyen N; Kanters JK; Jacobsen JR; Fosdal I; Wettrell G; Kjeldsen K
Am J Cardiol; 2005 Feb; 95(3):433-4. PubMed ID: 15670565
[TBL] [Abstract][Full Text] [Related]
30. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation.
Aromolaran AS; Srivastava U; Alí A; Chahine M; Lazaro D; El-Sherif N; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
PLoS One; 2018; 13(12):e0208321. PubMed ID: 30521586
[TBL] [Abstract][Full Text] [Related]
32. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
33. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
Fanoe S; Jensen GB; Sjøgren P; Korsgaard MP; Grunnet M
Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
[TBL] [Abstract][Full Text] [Related]
34. Functional characterization of a novel hERG variant in a family with recurrent sudden infant death syndrome: Retracting a genetic diagnosis.
Sergeev V; Perry F; Roston TM; Sanatani S; Tibbits GF; Claydon TW
Forensic Sci Int; 2018 Mar; 284():39-45. PubMed ID: 29331839
[TBL] [Abstract][Full Text] [Related]
35. In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant.
Lin MT; Wu MH; Chang CC; Chiu SN; Thériault O; Huang H; Christé G; Ficker E; Chahine M
Heart Rhythm; 2008 Nov; 5(11):1567-74. PubMed ID: 18848812
[TBL] [Abstract][Full Text] [Related]
36. Cardiac hERG K
Su S; Sun J; Wang Y; Xu Y
Handb Exp Pharmacol; 2021; 267():139-166. PubMed ID: 33829343
[TBL] [Abstract][Full Text] [Related]
37. Blockade of the Human Ether A-Go-Go-Related Gene (hERG) Potassium Channel by Fentanyl.
Tschirhart JN; Li W; Guo J; Zhang S
Mol Pharmacol; 2019 Apr; 95(4):386-397. PubMed ID: 30665971
[TBL] [Abstract][Full Text] [Related]
38. Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome.
Amin AS; Herfst LJ; Delisle BP; Klemens CA; Rook MB; Bezzina CR; Underkofler HA; Holzem KM; Ruijter JM; Tan HL; January CT; Wilde AA
J Clin Invest; 2008 Jul; 118(7):2552-61. PubMed ID: 18551196
[TBL] [Abstract][Full Text] [Related]
39. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
[TBL] [Abstract][Full Text] [Related]
40. Blockade of HERG human K+ channel and IKr of guinea pig cardiomyocytes by prochlorperazine.
Kim MD; Eun SY; Jo SH
Eur J Pharmacol; 2006 Aug; 544(1-3):82-90. PubMed ID: 16860311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
